CD274 and neoplasm: Tumour cells showed PD-L1 expression (TPS ≥1) in 39.5% (28–8; 17/43), 11.3% (22C3; 5/44), 51.2% (SP263; 22/43) and 0% (SP142, 0/45) (Fig. 1c).